These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 19286961)

  • 1. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
    Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How does Viagra protect the ischemic heart?
    Xia Y
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1209-10. PubMed ID: 19346460
    [No Abstract]   [Full Text] [Related]  

  • 3. Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats.
    Choi DE; Jeong JY; Lim BJ; Chung S; Chang YK; Lee SJ; Na KR; Kim SY; Shin YT; Lee KW
    Am J Physiol Renal Physiol; 2009 Aug; 297(2):F362-70. PubMed ID: 19474186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta.
    Das A; Xi L; Kukreja RC
    J Biol Chem; 2008 Oct; 283(43):29572-85. PubMed ID: 18723505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart.
    Salloum F; Yin C; Xi L; Kukreja RC
    Circ Res; 2003 Apr; 92(6):595-7. PubMed ID: 12637371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling.
    Das A; Xi L; Kukreja RC
    J Biol Chem; 2005 Apr; 280(13):12944-55. PubMed ID: 15668244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct renin inhibition with aliskiren protects against myocardial ischemia/reperfusion injury by activating nitric oxide synthase signaling in spontaneously hypertensive rats.
    Zhang W; Han Y; Meng G; Bai W; Xie L; Lu H; Shao Y; Wei L; Pan S; Zhou S; Chen Q; Ferro A; Ji Y
    J Am Heart Assoc; 2014 Jan; 3(1):e000606. PubMed ID: 24473199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
    Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective PKG-independent NO signaling at reperfusion.
    Cohen MV; Yang XM; Liu Y; Solenkova NV; Downey JM
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H2028-36. PubMed ID: 20852051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
    Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.
    Sánchez JA; Rodríguez-Sinovas A; Barba I; Miró-Casas E; Fernández-Sanz C; Ruiz-Meana M; Alburquerque-Béjar JJ; García-Dorado D
    Basic Res Cardiol; 2013 May; 108(3):351. PubMed ID: 23595215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of cGMP/protein kinase G pathway in postconditioned myocardium depends on reduced oxidative stress and preserved endothelial nitric oxide synthase coupling.
    Inserte J; Hernando V; Vilardosa Ú; Abad E; Poncelas-Nozal M; Garcia-Dorado D
    J Am Heart Assoc; 2013 Jan; 2(1):e005975. PubMed ID: 23525447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial protection evoked by hyperoxic exposure involves signaling through nitric oxide and mitogen activated protein kinases.
    Ruusalepp A; Czibik G; Flatebø T; Vaage J; Valen G
    Basic Res Cardiol; 2007 Jul; 102(4):318-26. PubMed ID: 17268885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sevoflurane post-conditioning protects isolated rat hearts against ischemia-reperfusion injury via activation of the ERK1/2 pathway.
    Xie H; Zhang J; Zhu J; Liu LX; Rebecchi M; Hu SM; Wang C
    Acta Pharmacol Sin; 2014 Dec; 35(12):1504-13. PubMed ID: 25345742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
    Ha T; Hu Y; Liu L; Lu C; McMullen JR; Kelley J; Kao RL; Williams DL; Gao X; Li C
    Cardiovasc Res; 2010 Sep; 87(4):694-703. PubMed ID: 20421349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
    Bulhak AA; Jung C; Ostenson CG; Lundberg JO; Sjöquist PO; Pernow J
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H719-27. PubMed ID: 19151258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the muscle-specific protein, melusin, protects from cardiac ischemia/reperfusion injury.
    Penna C; Brancaccio M; Tullio F; Rubinetto C; Perrelli MG; Angotti C; Pagliaro P; Tarone G
    Basic Res Cardiol; 2014 Jul; 109(4):418. PubMed ID: 24859929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
    Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
    Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes abolishes sildenafil-induced cGMP-dependent protein kinase-I expression and cardioprotection.
    Jamnicki-Abegg M; Weihrauch D; Chiari PC; Krolikowski JG; Pagel PS; Warltier DC; Kersten JR
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):670-6. PubMed ID: 18091584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat.
    Puerta E; Hervias I; Goñi-Allo B; Lasheras B; Jordan J; Aguirre N
    J Neurochem; 2009 Feb; 108(3):755-66. PubMed ID: 19187094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.